ResearcherUniversity of Virginia Health SystemActive in the last 2 years
Reid B. Adams
Matched on ORCID iD 0009-0007-0687-0567; OpenAlex author ID A5020089431. Sources: ClinicalTrials.gov.
Their work
- Papers
- 5
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2011: 2 papers · 2012: none · 2013: 1 trial · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Imaging Cell Surface Plectin in PDAC Patients - A First-In-Human Phase 0 Study Report. Co-author DOI 10.1007/s11307-025-02001-8↗
- Survival benefit associated with screening of patients at elevated risk for pancreatic cancer. Co-author DOI 10.1002/jso.27784↗
- Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer. Co-author PMID 24558510↗
- Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Co-author DOI 10.1245/s10434-010-1456-7↗
- Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma. Co-author DOI 10.1245/s10434-011-1693-4↗
Trials 1
- Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer Principal investigator NCT01962909↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Julien Dimastromatteo · 1 shared paper, 2025 · strength 0.37
- Kimberly A. Kelly · 1 shared paper, 2025 · strength 0.37
- Todd W. Bauer · 4 shared papers, 2011–2024 · strength 0.30
- Paper Survival benefit associated with screening of patients at elevated risk for pancreatic cancer. DOI 10.1002/jso.27784↗
- Paper Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer. PMID 24558510↗
- Paper Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarc… DOI 10.1245/s10434-011-1693-4↗
- William J. Kane · 1 shared paper, 2024 · strength 0.20
- Andrew Y. Wang · 1 shared paper, 2024 · strength 0.20
- Allan Tsung · 1 shared paper, 2024 · strength 0.20
- Sarbajeet Nagdas · 1 shared paper, 2024 · strength 0.20
- Vanessa M. Shami · 1 shared paper, 2024 · strength 0.20
- Jayme B. Stokes · 2 shared papers, 2011 · strength 0.06
- Dustin M. Walters · 2 shared papers, 2011 · strength 0.06
- Samhita Chakraborty · 1 shared paper, 2014 · strength 0.05
- Hanna Kelly Sanoff · 1 shared paper, 2014 · strength 0.05
- Tyvin A. Rich · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.